Date: 7.6.2019
Summary:
A Singapore-based institute has developed a rapid and reliable method for generating safe live attenuated vaccines (LAVs). Traditionally, attenuated strains are developed through serial passage in cell lines or in animals. This chance discovery can take years with no guarantee of success. With this new technology, it takes just 10 weeks for generation of a suitable LAV candidate.
The institute seeks to partner SMEs, MNEs and healthcare organisations via license or research agreements.
Reference: TOSG20190114002
Country: Singapore
Submitted: 7. 6. 2019
Keywords
Technology: Human vaccines
Market: Drug delivery and other equipment
NACE: Manufacture of basic pharmaceutical products; Manufacture of pharmaceutical preparations
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology links - Useful biotech links for you
Biotechnology dictionary - Biotechnology, dictionary, biotech words
Medical lab-on-a-chip runs 32 pathology tests at once
More than 100 magic mushroom genomes point the way to new cultivars